The increasing frequency of serious opportunist bacterial infections, especially those caused by gram-negative species in hospital patients, has heightened the need for developing and applying more effective antibiotics. Perhaps the most troublesome species among these microbial offenders are those included within Pseudomonas, Enterobacter, Serratia, and Klebsiella. Although at first glance it would appear that gentamicin and/or carbenicillin should adequately control infections by these bacteria, the toxicity limitations on gentamicin dosage remain a substantial impediment, and the problem of resistance development to carbenicillin also imposes a limitation. With these considerations in mind, the advent of a new aminoglycoside antibiotic, butirosin, stimulated our interest because early observations indicated that it had good activity experimentally against the aforementioned bacteria and at the same time held promise of being less toxic at therapeutic dose levels than could be expected for gentamicin (12). This publication presents more definitive experimental observations in vitro and in vivo in order to obtain a better understanding of the comparative antibacterial effectiveness of butirosin and gentamicin. A secondary objective was to develop a general guideline for eventual human dosages of butirosin to be derived from the interrelationship of antibacterial inhibitory concentrations in vitro, effective dosages in experimental mouse infections, and blood levels of butirosin in mice at effective dosages.
bacterial strains strongly resistant to GTM being moderately susceptible to BTN. In mice, after a single subcutaneous injection, absorption of both antibiotics was rapid, with peak serum levels occurring in 15 min; this was followed by rapid elimination with estimated serum half-lives of about 20 min for each. After peroral administration of high doses in mice, there was no appreciable absorption of BTN. Several tests were carried out to compare BTN and GTM with respect to minimal inhibitory concentrations in vitro, acute subcutaneous median mouse protective doses, peak serum levels at such doses, and the therapeutic ratios derived from acute median protective and lethal doses. Although GTM usually proved to be more potent antibacterially on a weight basis, observations on BTN indicated a superior effectiveness in terms of therapeutic ratios.
The increasing frequency of serious opportunist bacterial infections, especially those caused by gram-negative species in hospital patients, has heightened the need for developing and applying more effective antibiotics. Perhaps the most troublesome species among these microbial offenders are those included within Pseudomonas, Enterobacter, Serratia, and Klebsiella. Although at first glance it would appear that gentamicin and/or carbenicillin should adequately control infections by these bacteria, the toxicity limitations on gentamicin dosage remain a substantial impediment, and the problem of resistance development to carbenicillin also imposes a limitation. With these considerations in mind, the advent of a new aminoglycoside antibiotic, butirosin, stimulated our interest because early observations indicated that it had good activity experimentally against the aforementioned bacteria and at the same time held promise of being less toxic at therapeutic dose levels than could be expected for gentamicin (12) . This publication presents more definitive experimental observations in vitro and in vivo in order to obtain a better understanding of the comparative antibacterial effectiveness of butirosin and gentamicin. A secondary objective was to develop a general guideline for eventual human dosages of butirosin to be derived from the interrelationship of antibacterial inhibitory concentrations in vitro, effective dosages in experimental mouse infections, and blood levels of butirosin in mice at effective dosages.
MATERIALS AND METHODS
The antibiotics were handled, evaluated, and reported in terms of base content unless otherwise specified. We used butirosin sulfate (BTN) containing 710 sg of base per mg and gentamicin sulfate (GTM) containing 561 ;ig of base per mg. The latter was obtained through the generosity of Augustus Gibson of the Schering Corp.
Minimal inhibitory concentrations (MICs), for the most part, were determined by agar dilution in pH 7.4-adjusted Mueller-Hinton (agar) medium (MHA) according to the procedures recommended by the BUTIROSIN COMPARED WITH GENTAMICIN 125 International Collaborative Study (6) . To achieve reproducible results that are also consistent with those reported by other investigators, it is absolutely essential that each lot of MHA be "screened" before use. To accomplish this, the MICs of GTM against standard control organisms were compared on each new lot and a previously used acceptable lot of MHA. Twofold dilution decrements of antibiotic in MHA were inoculated with 100-fold-diluted, overnight, 37 C Mueller-Hinton broth (MHB) cultures. With a Steers multiple inoculator apparatus (25) , approximately 104 colony-forming units (CFU) of bacteria were delivered on each of 36 spots per plate. The MIC was determined as the lowest concentration of antibiotic producing virtually complete (< 5 colonies) inhibition of growth after overnight incubation at 37 C.
To determine the influence of culture media on their antibacterial activities, BTN and GTM were also tested for MICs in MHB and tryptic soy broth (TSB) by microtitration dilution (16) and tube dilution (12) procedures. In the microtitration test, 0.05-ml volumes of broth cultures diluted to contain approximately 100 CFU were added to equal volumes of broth containing twofold dilutions of antibiotic in microtitration wells (Linbro). Antibiotics were diluted with microtiter loops (Cooke). In the tube test, 0.1-ml volumes of 105-diluted cultures (approximately 2,000 CFU) were added to 5-ml volumes of broth containing twofold dilutions of antibiotic. In both cases, complete inhibition of macroscopically visible bacterial growth served as the end point. All cultures were grown in the test medium. All incubations were aerobic, 16 to 18 h, at 37 C. Some of the TSB-derived data were previously reported (12, 14) .
The influence of pH on the in vitro antibacterial activities of BTN and GTM were studied. Initially, a modification of the pH gradient plate method (24) was used. Gradients of pH 5.5 to 7.6 were made in square petri dishes (15 by 100 mm) by using Trypticase soy agar (TSA) in which 1.0 M solutions of the appropriate buffers had been diluted 10- fold-Na2HPO4 for the lower wedge and KH2PO4 for the upper. Dilutions (100-fold) of overnight 37 C TSB cultures of Klebsiella pneumoniae Marshall and Escherichia coli Vogel were swabbed over the agar surfaces. Filter paper strips saturated with 1,000 Ag of BTN and GTM per ml were placed in parallel along the pH gradients. After 37 C overnight incubation, the width of the inhibition zones on the acid and alkaline sides of the gradient was compared. The pH effect was also tested by determining the MIC of BTN and GTM versus that of various bacteria in the microtitration dilution procedure. Test broths were TSB adjusted to pH 5.5, 7.0, and 8.5.
The influence of anaerobiosis on in vitro antibacte- (30) reported on the use of a Mueller-Hinton medium supplemented with 5% defibrinated sheep blood to determine the agar dilution MICs of various aminoglycoside antibiotics versus gram-negative bacteria by the International Collaborative Study procedure. To find out whether the results obtained on MHA with blood differed appreciably from those obtained with plain MHA, since the latter was used in the studies described in our publication, a side-by-side comparison of the two media to determine the MIC of BTN and GTM versus various Enterobacteriaceae and Pseudomonas aeruginosa was performed.
Disk agar diffusion susceptibility tests were performed by methods described by Bauer et al. (3) . TSB-grown cultures were diluted in saline to match a nephelometer standard (McFarland no. 1 diluted twofold) and thoroughly swabbed on MHA plates. Inhibition zone diameters surrounding antibiotic-containing 6-mm filter paper disks were recorded after overnight 37 C incubation. The disks used were GTM (10 Mg) and BTN (30 Mg), the latter obtained through the courtesy of Baltimore Biological Laboratories. The relationships between MIC values and respective zone diameters were depicted by the graphic procedures of Bauer et al. (3) and mathematically as least-mean square-derived regression lines (2) . A large number of putative resistant clinical isolates were accumulated for these tests from various sources so that the antibiotic-resistant areas of the regression lines would receive adequate treatment.
All in vivo tests were done in 18-to 22-g female CF-1 mice (Carworth). The mice received mouse laboratory chow (Purina) and water ad libitum. All injections were subcutaneous (sc) in 0.5-ml volumes in physiological saline.
To determine blood levels of BTN and GTM achieved in mice, single doses of 300, 100, 30, 10, and 3 mg of BTN per kg and 100, 30, 10, 3, and 1 mg of GTM per kg (both in terms of total sulfate) were administered sc. At each level, groups of five mice were bled by open-thorax cardiac puncture at 15, 30, 60 , and 120 min after dosing. Pooled serum samples were assayed by using a paper disk, agar diffusion method similar to those used for viomycin (5, 14) . The organism in this case, however, was Bacillus subtilis ATCC 6633, and dilutions were prepared in pH 7.1 0.1 M potassium phosphate buffer. The susceptibilitiy limits of the assay are 0.3 Mg of base per ml for both BTN and GTM.
Elimination half-lives were estimated, for all dose levels, by using semi-log graph paper on which the declining serum levels (in micrograms per milliliter) were plotted on the logarithmic scale versus the sampling times. Plots relating logarithms of single sc doses of BTN and GTM to logarithms of peak serum levels were also prepared.
To determine oral absorption, groups of four mice were given by intubation single doses of 1,000 and 100 mg of BTN per kg (in terms of total sulfate) in 0.5-ml To determine the subacute mouse toxicity of BTN and GTM, 1.5-fold graded doses of the antibiotics were administered sc to groups of 10 mice twice daily in two 5-day series, separated by a 2-day rest interval. Deaths were recorded daily and accumulated for a total of 25 days. The subacute sc median lethal doses (LD,O) were estimated by the log-probit procedure (18) .
Mouse protection studies were performed as previously described (12) . Single sc antibiotic doses, twofold rising incremental series, were administered concurrently with the lethal bacterial challenge, which were accomplished by the intraperitoneal injection of an estimated 100 LD50 suspended in 0.5 ml of 5% hog gastric mucin (except for K. pneumoniae given in TSB). Generally at least 90% of untreated controls died in 48 to 72 h. Final survival percentages, obtained after 7 days of observation among groups of 10 to 15 mice, were used to estimate median protective doses (PD55) (18) .
RESULTS
Inhibition tests in vitro simultaneously comparing BTN and GTM versus various bacteria were run at different times in MHA, MHB, and TSB (Table 1) . Since identical results were obtained by microtitration dilution and tube dilution procedures, such data were combined. These tests revealed the significant influence that the culture medium had on the apparent in vitro activity of these antibiotics, as would be anticipated from the reports of, for example, Barber and Waterworth (1) and Garrod and Waterworth (9) . MIC values in MHA and TSB were from three-to ninefold greater than those obtained in MHB. Results in TSB, the medium used in previously reported studies (12, 14) , were generally between one-half to twice those obtained in MHA, the medium currently recom- Tables 2 and 3 ).
The influence of anaerobiosis on the antibacterial activities of BTN and GTM in vitro was (15) . Based on preliminary, unpublished toxicological and human blood level and tolerance studies and the fact that BTN is about one-fourth as active as GTM in mouse-protective activity, a "susceptibility cut-off" for BTN of 25 ,ug/ml was tentatively selected. To attain inhibition zones greater than 12 mm with susceptible cultures, 30-,ug BTN disks were required. Similar MICzone diameter regression lines were obtained with both GTM and BTN. The validity of these MIC-zone diameter relationships is supported by correlation coefficients of -0.91 for BTN and -0.87 for GTM, both of which are very highly significant. However, the distribution of the points prohibits use of the mathematical regressions for calculating MIC values on the basis of observed zone diameters (26) .
In Table 6 , the relative frequency of bacterial strains resistant to either or both BTN and GTM and their MHA-dilution MIC values are shown, using the above-mentioned arbitrary susceptibility cut-off points. Whereas in the MIC-zone diameter relationships all resistant isolates with MIC values fitting the graph were used, great care was taken to assure that no more than two seemingly identical isolates from the same source, presumably representing the same "strain," were included in this analysis. Differentiation of P. aeruginosa isolates was facilitated by use of the Fisher-DevlinGnabasik (8) Similar results, serum level profiles, were obtained with GTM which agreed with previously published data (19, 27) . The mouse serum level profile of BTN after single sc doses of 71 mg/kg (100 mg of sulfate per kg) (Fig. 3) characterized the data obtained at all levels of BTN and GTM tested. The compounds were rapidly absorbed, reached a peak level by 15 min, and were rapidly eliminated. The average half-lives of BTN and GTM were 22 and 20 min, respectively ( Table 7) .
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The linear relationships between sc dose and peak serum levels of both BTN and GTM, on a full-log plot, are illustrated in Fig. 4 . The correlations were excellent (r = 0.997 for BTN and 0.998 for GTM). BTN was very poorly absorbed from the oral route in mice (Table 8) . Almost all of the oral dose was excreted directly in the feces with very little going to the blood or urine. The small amount in the feces after sc dosing may reflect urinary contamination of the fecal material.
The subacute sc toxicities of BTN and GTM were determined as described. The LD50 values, in terms of milligrams per kilogram per dose and 95% confidence limits, were 4,260 (3,838 to 4,682) for BTN and 340 (299 to 429) for GTM. Thus, 12.5 times as much BTN as GTM was required to kill 50% of the mice.
Against several strains of Enterobacteriaceae and P. aeruginosa, selected on the basis of their susceptibility or resistance to GTM (based on MICs and zone diameters), single sc-dose PD50 values of BTN and GTM were determined in parallel side-by-side acute, single sc-dose mouse protection tests. From the PD50 values, by means of the regression lines in Fig. 4 , the corresponding effective peak serum levels were approximated (19) . Finally, approximate mouse-test therapeutic ratios of BTN and GTM were determined by dividing the PD50 values into the subacute, sc-dose LD50 (11) . The in vitro and mouse potency parameters for each antibiotic versus each organism-MIC by agar dilution in MHA, inhibition zone diameter by Bauer-Kirby procedure, estimated single scdose PD50, expected peak serum level at PD50, and approximate therapeutic ratio-are presented side by side for GTM versus Enterobacteriaceae in Table 9 , BTN versus Enterobacteriaceae in Table 10 , GTM versus P. aeruginosa in Table 11 , and BTN versus P. aeruginosa in Table 12 . The strains were divided into GTM susceptible, intermediate, and resistant based on MIC and zone diameter criteria. In Table 13 , geometric mean MICs, geometric mean PD50 values, expected peak mouse serum levels at PD50 values and therapeutic ratios at geometric mean PD50 of both BTN and GTM, and the BTN/GTM activity ratios versus GTM-susceptibility Enterobacteriaceae and P. aeruginosa are compared. A review of Tables 9 through 12 revealed, as before, a good negative correlation between MICs and values, and concomitant peak mouse serum levels were roughly parallel. However, more often than not (61% overall) the expected peak serum levels, derived from the PD50 values, were more than twice the in vitro MICs. Only in 53% of the cases were the peak blood levels within a twofold range of the MICs among GTM-resistant strains, and only 27% were in this category in the GTM-susceptible group. GTM appeared more potent in terms of drug concentration values than BTN in several in vitro and mouse-test categories (Table 13) . Of greatest significance is the fact that the therapeutic ratio favors BTN in the therapy of experimental infections in mice. Table 9 .
DISCUSSION
As in the case with GTM and other aminoglycosides, BTN activity in vitro is influenced by the nature of the culture medium, pH of the medium, and aerobiosis. The relationship between increasing MICs and increasing concentrations of calcium and magnesium in the various culture media, as well as the possible mechanisms for this effect on aminoglycosides, especially GTM, have been discussed in great detail by Garrod 
